Table 1.

Patient characteristics

ParameterUCT (N = 6)iTACO (N = 33)cTACO (N = 33)P value
Age, y 70 (62-75) 62 (55-69) 69 (59-75) .13 
Females, % (n/N) 33.3 (2/6) 39.4 (13/33) 48.5 (16/33) .67 
Body mass index 25 (23-27) 28 (24-33) 27 (26-30) .50 
Hypertension, % (n/N) 16.7 (1/6) 30.3 (10/33) 24.2 (8/33) .73 
Diabetes, % (n/N) 50 (3/6) 18.2 (6/33) 18.2 (6/33) .18 
Renal disease, % (n/N) 0 (0/6) 18.2 (6/33) 30.3 (10/33) .19 
Cardiovascular disease, % (n/N) 16.7 (1/6) 39.4 (13/33) 42.4 (14/33) .49 
Malignancy, % (n/N) 0 (0/6) 27.3 (9/33) 12.1 (4/33) .14 
Inpatient, % (n/N) 83.3 (5/6) 87.9 (29/33) 75.8 (25/33) .44 
Volume transfused, mL 294 (198-345) 283 (175-326) 225 (140-308) .62 
Infusion rate, mL/h 120 (120-120) 104 (94-138) 94 (72-110) .04 
Peritransfusion furosemide, % (n/N) 0 (0/6) 21.2 (7/33) 63.6 (21/33) <.01 
Oxygen requirement, % (n/N) 0 (0/6) 3.0 (1/33) 9.1 (3/33) .44 
ParameterUCT (N = 6)iTACO (N = 33)cTACO (N = 33)P value
Age, y 70 (62-75) 62 (55-69) 69 (59-75) .13 
Females, % (n/N) 33.3 (2/6) 39.4 (13/33) 48.5 (16/33) .67 
Body mass index 25 (23-27) 28 (24-33) 27 (26-30) .50 
Hypertension, % (n/N) 16.7 (1/6) 30.3 (10/33) 24.2 (8/33) .73 
Diabetes, % (n/N) 50 (3/6) 18.2 (6/33) 18.2 (6/33) .18 
Renal disease, % (n/N) 0 (0/6) 18.2 (6/33) 30.3 (10/33) .19 
Cardiovascular disease, % (n/N) 16.7 (1/6) 39.4 (13/33) 42.4 (14/33) .49 
Malignancy, % (n/N) 0 (0/6) 27.3 (9/33) 12.1 (4/33) .14 
Inpatient, % (n/N) 83.3 (5/6) 87.9 (29/33) 75.8 (25/33) .44 
Volume transfused, mL 294 (198-345) 283 (175-326) 225 (140-308) .62 
Infusion rate, mL/h 120 (120-120) 104 (94-138) 94 (72-110) .04 
Peritransfusion furosemide, % (n/N) 0 (0/6) 21.2 (7/33) 63.6 (21/33) <.01 
Oxygen requirement, % (n/N) 0 (0/6) 3.0 (1/33) 9.1 (3/33) .44 

Median and interquartile range are shown unless specified otherwise. P values in boldface type represent statistical significance (P ≥ .05).

or Create an Account

Close Modal
Close Modal